Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4778441

C=CC(=O)NCc1oc2ccccc2c1C.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.42
▸ RAB9A P51151 4/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.41
▸ MTNR1A P48039 3/20 0.40
▸ MTNR1B P49286 3/20 0.40
▸ GAA P10253 1/20 0.38
▸ GPR55 Q9Y2T6 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ EGFR P00533 1/20 0.37
▸ BTK Q06187 1/20 0.37
▸ TGM2 P21980 1/20 0.37
▸ HTT P42858 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3973246 0.92 NPC1 (0.47) NPC1RAB9ASMN1; SMN2RXFP1MTNR1A
Trifluoroacetic Acid SCHEMBL4777180 0.84 NPC1 (0.43) NPC1RAB9ASMN1; SMN2RXFP1MTNR1A
Trifluoroacetic Acid SCHEMBL4777187 0.78 HCRTR1 (0.39) NPC1RAB9ASMN1; SMN2EGFRHTT
SCHEMBL5269323 0.75 MTNR1A (0.47) MTNR1AMTNR1BTGM2
Trifluoroacetic Acid SCHEMBL4778437 0.74 CAPN1 (0.38) NPC1RAB9ARXFP1L3MBTL1HTT
SCHEMBL23532112 0.74 NR1I3 (0.58) NPC1RAB9ASMN1; SMN2RXFP1MTNR1A
SCHEMBL4778585 0.74 NPC1 (0.46) NPC1RAB9ASMN1; SMN2RXFP1MTNR1A
Hydrochloric Acid SCHEMBL30481157 0.73 NPC1 (0.45) NPC1RAB9ASMN1; SMN2RXFP1MTNR1A
SCHEMBL23532074 0.72 ABL1 (0.41) RAB9ASMN1; SMN2GAAL3MBTL1BTK
Trifluoroacetic Acid SCHEMBL27785538 0.68 KCNH2 (0.49) NPC1RAB9ASMN1; SMN2RXFP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1973902-A2 3-HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS Affinium Pharmaceuticals, Inc. (CA) 2008-10-01 — — EP disclosed
WO-2007067416-A2 HETEROCYCLYLACRYLAMIDE COMPOUNDS AS FABI INHIBITORS AND ANTIBACTERIAL AGENTS AFFINIUM PHARMACEUTICALS, INC. (CA) 2007-06-14 — — WO disclosed
Send feedback